Eikon Therapeutics, Inc. (EIKN) Ownership Overview
22.31% Insiders
1.42% Mutual Funds
20.21% Other Institutional Investors
4.02% ETFs
52.03% Public Companies and
Individual Investors
The ownership structure of Eikon Therapeutics, Inc. (EIKN) stock is a mix of institutional, retail, and individual investors. Approximately 25.65% of the company’s stock is owned by Institutional Investors, 22.31% is owned by Insiders, and 52.03% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Feb 09, 2026 | xxxxxxxxxxxxx | $38119680 | |
Feb 06, 2026 | xxxxxxxxxxxxx | $999990 | |
Feb 06, 2026 | xxxxxxxxxxxxx | $4999968 | |
Feb 06, 2026 | xxxxxxxxxxxxx | $4999968 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Mar 31, 2026 | xxxxxxxxxxxxx | $5877772 | |
Mar 31, 2026 | xxxxxxxxxxxxx | $1781016 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,780,143 | Insider | 10.67% | 60,518,097 | |
| 2,294,653 | Insider | 4.24% | 24,025,017 | |
| 2,294,653 | Insider | 4.24% | 24,025,017 | |
| 1,318,983 | Insider | 2.44% | 13,809,752 | |
| 1,050,113 | Institution | 1.94% | 10,994,683 | |
| 807,787 | Institution | 1.49% | 8,457,530 | |
| 555,555 | Institution | 1.03% | 5,816,661 | |
| 490,769 | Institution | 0.91% | 5,138,351 | |
| 284,857 | Insider | 0.53% | 2,982,453 | |
| 168,338 | Institution | 0.31% | 1,762,499 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 490,769 | Institution | 0.91% | 5,138,351 | |
| 138,867 | Institution | 0.26% | 1,453,937 | |
| 127,376 | Institution | 0.24% | 1,333,627 | |
| 14,000 | Institution | 0.03% | 146,580 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 660,117 | Institution | 1.22% | 6,079,678 | |
| 530,920 | Institution | 0.98% | 5,558,732 | |
| 241,101 | Institution | 0.45% | 2,220,540 | |
| 137,517 | Institution | 0.25% | 1,439,803 | |
| 122,457 | Institution | 0.23% | 1,127,829 | |
| 99,059 | Institution | 0.18% | 1,094,602 | |
| 75,505 | Institution | 0.14% | 790,537 | |
| 63,525 | Institution | 0.12% | 665,107 | |
| 61,904 | Institution | 0.11% | 648,135 | |
| 39,229 | Institution | 0.07% | 410,728 |
FAQ
Who Owns Eikon Therapeutics, Inc. (EIKN)?
According to the latest TipRanks data, approximately 20.21% of the company's stock is held by institutional investors, 22.31% is held by insiders, and 52.03% is held by retail investors.
What percentage of Eikon Therapeutics, Inc. (EIKN) stock is held by institutional investors?
According to the latest TipRanks data, approximately 20.21% of Eikon Therapeutics, Inc. (EIKN) stock is held by institutional investors.
What percentage of Eikon Therapeutics, Inc. (EIKN) stock is held by retail investors?
According to the latest TipRanks data, approximately 52.03% of Eikon Therapeutics, Inc. (EIKN) stock is held by retail investors.
Who owns the most shares of Eikon Therapeutics, Inc. (EIKN)?
Column Group GP IV LP owns the most shares of Eikon Therapeutics, Inc. (EIKN).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.